These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 27262841)

  • 1. High density lipoprotein subfractions and paraoxonase 1 in children.
    Muchová J; Andrezálová L; Oravec S; Nagyová Z; Garaiova I; Ďuračková Z
    Acta Biochim Pol; 2016; 63(3):555-63. PubMed ID: 27262841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paraoxonase 1 and HDL subfractions in hypercholesterolemic children and adolescents.
    Duracková Z; Muchová J; Andrezálová L; Oravec S; Nagyová Z; Garaiova I
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S29. PubMed ID: 26461330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered lipid subfraction profile and impaired antioxidant defense of high-density lipoprotein in Smith-Lemli-Opitz syndrome.
    Lőrincz H; Harangi M; Oláh AV; Szabó GP; Fülöp P; Somodi S; Paragh G; Seres I
    Pediatr Res; 2015 May; 77(5):703-9. PubMed ID: 25668223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
    Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
    Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus.
    Gaál K; Tarr T; Lőrincz H; Borbás V; Seres I; Harangi M; Fülöp P; Paragh G
    Lipids Health Dis; 2016 Mar; 15():60. PubMed ID: 27004558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood.
    Gugliucci A; Numaguchi M; Caccavello R; Kimura S
    Redox Rep; 2014 May; 19(3):124-32. PubMed ID: 24620935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease.
    Rysz-Gorzynska M; Gluba-Brzozka A; Banach M
    Curr Vasc Pharmacol; 2017; 15(2):144-151. PubMed ID: 27697068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.
    Rosenblat M; Karry R; Aviram M
    Atherosclerosis; 2006 Jul; 187(1):74-81. PubMed ID: 16229851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VLDL triglycerides inhibit HDL-associated paraoxonase 1 (PON1) activity: in vitro and in vivo studies.
    Rosenblat M; Ward S; Volkova N; Hayek T; Aviram M
    Biofactors; 2012; 38(4):292-9. PubMed ID: 22674772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and difficulties in measuring HDL subfractions and human paraoxonase-1 activity during statin treatment.
    Harangi M; Seres I; Harangi J; Paragh G
    Cardiovasc Drugs Ther; 2009 Dec; 23(6):501-10. PubMed ID: 19859794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I.
    Gaidukov L; Tawfik DS
    Biochemistry; 2005 Sep; 44(35):11843-54. PubMed ID: 16128586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum paraoxonase-1 activity in children: the effects of obesity and insulin resistance.
    Agirbasli M; Tanrikulu A; Erkus E; Azizy M; Sevim BA; Kaya Z; Taskin A; Aksoy N; Demirbag R
    Acta Cardiol; 2014 Dec; 69(6):679-85. PubMed ID: 25643439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of amino-terminal C-type natriuretic peptide serum level and its correlation with high-density lipoprotein structure and function in patients with end stage renal disease before and after kidney transplantation.
    Szentimrei R; Lőrincz H; Szentpéteri A; Varga VE; Seres I; Varga É; Nemes B; Harangi M; Paragh G
    Chem Biol Interact; 2023 Nov; 385():110749. PubMed ID: 37802408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PON1 arylesterase activity, HDL functionality and their correlation in malnourished children.
    Mogarekar MR; Dhabe MG; Palmate MM
    J Pediatr Endocrinol Metab; 2019 Apr; 32(4):321-326. PubMed ID: 30875327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
    Xu RX; Guo YL; Li XL; Li S; Li JJ
    Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine paraoxonase 1 activities in serum and distribution in lipoproteins.
    Miyamoto T; Takahashi Y; Oohashi T; Sato K; Oikawa S
    J Vet Med Sci; 2005 Mar; 67(3):243-8. PubMed ID: 15805725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects.
    Dullaart RP; Otvos JD; James RW
    Clin Biochem; 2014 Aug; 47(12):1022-7. PubMed ID: 24769273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.
    Passaro A; Vigna GB; Romani A; Sanz JM; Cavicchio C; Bonaccorsi G; Valacchi G; Cervellati C
    Oxid Med Cell Longev; 2018; 2018():1752940. PubMed ID: 30524650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Lipoprotein Subfractions in 920 Patients With and Without Type 2 Diabetes.
    Zhao X; Zhang HW; Zhang Y; Li S; Xu RX; Sun J; Zhu CG; Wu NQ; Gao Y; Guo YL; Liu G; Dong Q; Li JJ
    Heart Lung Circ; 2017 Mar; 26(3):211-218. PubMed ID: 28027866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.